Back

Intellia secures $400 million loan tied to lonvo-z milestones

Verifying
  • Intellia Therapeutics secured a senior secured term loan from OrbiMed.
  • $75 million was funded at closing from the $400 million facility.
  • Lonvo-z has produced positive Phase 3 HAELO results and entered rolling BLA submission.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Intellia secures $400 million loan tied to lonvo-z milestones - CoinPost Terminal